Berman Capital Advisors, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$9,000
+80.0%
55
+19.6%
0.00%0.0%
Q2 2021$5,000
-16.7%
46
-2.1%
0.00%0.0%
Q1 2021$6,000
+20.0%
47
+2.2%
0.00%0.0%
Q4 2020$5,0000.0%460.0%0.00%0.0%
Q3 2020$5,000
+66.7%
46
+35.3%
0.00%0.0%
Q2 2020$3,0000.0%340.0%0.00%0.0%
Q1 2020$3,000340.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders